Uniarm Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-06-2024
- Paid Up Capital ₹ 1.00 M
as on 02-06-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
About Uniarm Biotech
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Mehta, Dharmendra Gaur, Manoj Pandey, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2019PTC320876
- Company No.
320876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uniarm Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Mehta  | Additional Director | 14-Dec-2022 | Current |
| Dharmendra Gaur | Additional Director | 14-Dec-2022 | Current |
| Manoj Pandey | Director | 01-Apr-2019 | Current |
| Atul Pandey | Director | 01-Apr-2019 | Current |
Financial Performance of Uniarm Biotech.
Uniarm Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Uniarm Biotech?
Unlock access to Uniarm Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Atul Engg And Construction Private LimitedActive 22 years 12 daysManoj Pandey and Atul Pandey are mutual person
- Sonbhadra Automobiles Private LimitedActive 22 years 3 months
Manoj Pandey and Atul Pandey are mutual person
- Om Autovehicles Private LimitedActive 11 years 9 months
Manoj Pandey and Atul Pandey are mutual person
- Om Transport Services Private LimitedActive 2 years 7 months
Manoj Pandey and Atul Pandey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uniarm Biotech?
Unlock and access historical data on people associated with Uniarm Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uniarm Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniarm Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
